Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
EN
SV
Press releases
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2025
2024
2023
2022
2024
2024-05-28 08:00
Last day of trading with warrants of series TO6 in Prolight Diagnostics is today, May 28, 2024
Regulatory
2024-05-27 20:35
Annual general meeting of Prolight Diagnostics AB (publ) on 27 May 2024
Regulatory
2024-05-23 08:00
Prolight on track for clinical performance studies
2024-05-20 08:00
Prolight initiates trial at London hospital Trust supported by an NIHR i4i PDA grant
2024-05-20 07:45
The exercise period for warrants of series TO6 in Prolight Diagnostics begins today
Regulatory
2024-05-17 08:15
Prolight Diagnostics publishes quarterly report Q1, 2024
Regulatory
MAR
2024-05-17 08:00
Prolight Diagnostics awarded SEK17M UK government grant in collaboration with leading UK hospital Trust
2024-05-16 20:35
The exercise price for the warrants of series TO6 in Prolight Diagnostics has been determined to SEK 0.10 per share
Regulatory
2024-05-02 08:00
Prolight selects MDx CRO for the clinical performance studies for Psyros™
Regulatory
2024-04-30 11:20
Prolight Diagnostics AB (publ) publishes annual report for 2023
Regulatory
Previous
Next
